Document is current
Any future updates will be listed below
-
Authors
Marcucci, Gemma
Masi, Laura
Cianferotti, Luisella
Giusti, Francesca
Fossi, Caterina
Parri, Simone
Gronchi, Giorgio
Brandi, Maria Luisa http://orcid.org/0000-0002-8741-0592
-
Funding
Funding for this research was provided by:
AIFA (-)
- License Information
-
More Information
Article History
Received: 21 October 2020
Accepted: 26 November 2020
First Online: 4 February 2021
Change Date: 8 April 2021
Change Type: Update
Change Details: The original online version of this article was revised: The funding note for open access added.
Compliance with ethical standards
:
: M.L.B. is a consultant for Alexion, Bruno Farmaceutici, Shire, Servier, Kyowa Kirin; academic grants and/or speaker: Abiogen, Alexion, Amgen, Bruno Farmaceutici, Eli Lilly, Kyowa Kirin, MSD, NPS, Servier, Shire, SPA; she has received honoraria from Amgen, Bruno Farmaceutici, Kyowa Kirin. L.C. received speaking fees from Bruno Farmaceutici, Abiogen Pharma, Shire, Sandoz; she is a consultant for UCB. The remaining authors declare that they have no conflicts of interest or disclosures.
: The study was approved by the Investigator Board of the University Hospital of Florence and AIFA (Code-EUDRACT:2013-001890-26). All subjects participating in the study signed an informed consent form, and all personal, clinical, and biological data were collected in accordance with the Declaration of Helsinki.
